Profile Results for Aplastic Anemia
-
Medicine Male Expertise Aplastic Anemia, Bone Marrow Failure...
Dr. Robert Brodsky is a professor of medicine at the Johns Hopkins University School of Medicine. His area of clinical expertise is hematology. Through research, he and his colleagues have pioneered the use of high-dose cyclophosphamide therapy for t... -
Myeloid Leukemia (AML), Aplastic Anemia, Blood Transplant, Bone...
Richard J. Jones, M.D., is a Professor of Oncology and Medicine, Director of the Bone Marrow Transplantation Program, and Co-Director of the Hematologic Malignancies Program at The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. Dr. Jones... -
Myeloid Leukemia (AML), Aplastic Anemia, Bone Marrow Failure...
Dr. Amy DeZern is a hematologist and medical oncologist at the Sidney Kimmel Comprehensive Cancer Center and is an Associate Professor of Oncology and Medicine at the Johns Hopkins University School of Medicine. She received her medical degree in 200... -
of hepatitis-associated aplastic anemia with high-dose...with sickle cell anemia. Pediatr Blood Cancer
Dr. Resar's studies molecular mechanisms leading to cancer, blood diseases, sickle cell anemia, hemophilia and other coagulopathies. Her research focuses on the HMG-I/Y gene family, which is widely overexpressed and functions as oncogenes in human ca... -
bone marrow failure/aplastic anemia, lung disease including...
My clinical and research interests focus on disorders caused by telomere dysfunction. Our goal is to define approaches to surveillance, diagnosis and treatment for patients with telomere-mediated disease. Human syndromes associated with telomere shor... -
cyclophosphamide for severe aplastic anemia: long-term follow...
-
Myeloid Leukemia (AML), Aplastic Anemia, Bone Marrow Transplant...
In her first decade as a pediatric oncologist, Dr. Symons already has shown an impressive ability to juggle multiple research projects, in addition to caring for patients.One of Dr. Symons' research pursuits focuses on using a novel immunotherapy app... -
CD34 cells in aplastic anemia and hypoplastic myelodysplastic...
-
cyclophosphamide for severe aplastic anemia: long-term follow...
Chen's primary area of research focuses on bone marrow transplantation (BMT), a highly complex and specialized aspect of pediatric oncology that, in recent years, has become an accepted form of therapy for an increasingly broad range of cancers. In a... -
cyclophosphamide for severe aplastic anemia: long-term follow...
Richard F. Ambinder, M.D., Ph.D., currently serves as the James B. Murphy Professor of Oncology and the Director of the Division of Hematologic Malignancies at the Johns Hopkins Kimmel Cancer Center. He is program co-leader of the Hematologic Maligna...